Guideline Central Blog

Guidelines

What's Changed & Predictions Hyperlipidemia

Pharmacological Management for Hyperlipidemia – What’s Changed Since+ Predictions

High cholesterol, also known as hyperlipidemia, affects millions of individuals in the United States (US). This condition can lead to serious health issues, such as an increased risk of heart disease and stroke. Globally, approximately one-third of cases of ischaemic heart disease are linked to high cholesterol levels. Elevated total cholesterol is a significant contributor […]

Guidelines Spotlight Immunization Schedules for Adults and Children

Immunization Schedules for Adults and Children – Guidelines Spotlight (National Immunization Awareness Month)

As we prepare for the National Immunization Awareness Month 2024 and upcoming autumn season, we will be conducting a thorough review of the United States Immunization Schedules for both Adults and Children. These crucial recommendations are released annually by the Centers for Disease Control and Prevention (CDC). They offer essential guidance on the recommended schedules […]

What's Changed Rheumatoid Arthritis (RA)

Rheumatoid Arthritis (RA) – What’s Changed?

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by systemic inflammation primarily affecting the synovial joints. This condition arises from an aberrant immune response targeting the synovium, leading to persistent inflammation, joint damage, and potential systemic manifestations. If left untreated, RA can cause significant damage to the joints and surrounding tissues, potentially leading to […]

AAN’s Migraine Prevention Guideline is Now Open for Public Comment

The American Academy of Neurology (AAN) has announced that their latest guideline, “Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Update: Report of the AAN Guidelines Subcommittee,” is now open for public comment. This practice guideline offers updated evidence-based conclusions and recommendations on the use of pharmacologic migraine prevention in adults. The primary objective […]

Guidelines Timeline - AGS Beers Criteria

Comparing the American Geriatrics Society (AGS) Beers Criteria – Guidelines Timeline

The American Geriatrics Society (AGS) Beers Criteria® for Potentially Inappropriate Medication (PIM) Use in Older Adults is a widely recognized and utilized tool in the healthcare community. The AGS Beers Criteria is regularly updated every 3-4 years to ensure its relevance and accuracy in guiding healthcare professionals in prescribing medications for individuals aged 65 and […]

What's Changed & Predictions Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy – What’s Changed Since+ Predictions Series

Duchenne Muscular Dystrophy (DMD) is a severe inherited neuromuscular disorder caused by mutations in the dystrophin gene. It leads to progressive muscle wasting and irreversible functional decline. Primarily affecting males due to X-linked recessive inheritance, DMD can also rarely affect females. Symptoms include gradual muscle atrophy and fibrous tissue replacement in skeletal and cardiac muscles. […]

What's Changed & Predictions Thyroid Eye Disease (TED)

Thyroid Eye Disease (TED) – What’s Changed Since+ Predictions

Thyroid eye disease (TED), also known as Graves’ orbitopathy, is a complex immune-mediated disorder characterized by the aberrant proliferation of orbital fibroblasts, adipogenesis, glycosaminoglycan and mucin deposition. This connective tissue remodeling results in edematous, fibrotic adipose tissue and inflammation within the orbit and underlies the consequential classic presentation of proptosis, where the eyes appear pushed […]

What's Changed & Predictions Treatment of Patients With Schizophrenia

Treatment of Patients With Schizophrenia – What’s Changed Since+ Predictions Series

Among the top 10 causes of disability worldwide, schizophrenia’s relatively low prevalence is starkly contrasted by its profound impact on functional capacity and quality of life. With the National Institute of Mental Health estimating its prevalence in the US to range between 0.25% and 0.64%, schizophrenia is a disproportionately significant contributor to the global burden […]

What's Changed - NCCN Soft Tissue Sarcoma (STS)

Soft Tissue Sarcoma – What’s Changed?

The American Cancer Society projects that in the United States alone in 2024, approximately 13,590 new cases of soft tissue sarcomas (STS) will be diagnosed, with 7,700 cases in males and 5,890 cases in females. Additionally, it is projected that about 5,200 individuals are expected to die from soft tissue sarcomas. It is important to […]

Guidelines Rundown - Substance Use & Mental Health

Substance Use & Mental Health – Guidelines Rundown 

We understand the critical role you play in supporting patients and communities impacted by substance use and mental health disorders. To aid your efforts, we’ve compiled a comprehensive list of essential guidelines from leading medical societies published in recent years. These guidelines are designed to enhance your practice and improve patient outcomes. Your dedication to […]

Guidelines Spotlight - Age-Related Hearing Loss

Age-Related Hearing Loss – Guidelines Spotlight

According to the National Institute on Deafness and Other Communication Disorders (NIDCD), age-related hearing loss (ARHL) or presbycusis is a prevalent condition among aging adults. Approximately 15% of American adults aged 18 and over report experiencing some degree of hearing difficulty, with one in three individuals between the ages of 65 and 74 experiencing hearing […]

What's Changed & Predictions Age-Related Macular Degeneration

Age-Related Macular Degeneration Guidelines – What’s Changed Since & Guidelines Prediction Series

As the leading cause of irreversible blindness in adults 60 years of age and older, age-related macular degeneration (AMD) is a prevalent eye condition marked by central vision loss that impacts nearly 20 million individuals in the US. Despite its prevalence, afflicting approximately 1 in every 8 individuals above 60 years of age, there are […]

Guidelines Spotlight - Stimulant Use Disorder

Stimulant Use Disorder – Guidelines Spotlight

The American Society of Addiction Medicine (ASAM) and the American Academy of Addiction Psychiatry (AAAP) collaborated to develop the Clinical Practice Guideline on the Management of Stimulant Use Disorder (referred to as the Guideline). It was published on November 8, 2023. The Guideline aims to provide evidence-based strategies and clinically informed standards of care for […]

ACOG Pregnancy & Postpartum Algorithms

New Pregnancy and Postpartum Algorithms Published by ACOG

The American College of Obstetricians and Gynecologists (ACOG) and the Centers for Disease Control and Prevention (CDC) have collaborated on a multiyear initiative entitled “Identifying and Managing Obstetric Emergencies in Nonobstetric Settings.” This initiative addresses pregnancy-related emergencies and complications such as cardiomyopathy, preeclampsia, eclampsia, and stroke, as well as mental health conditions that can pose […]

AGA’s Ulcerative Colitis Guideline is Now Open for Public Comment

The American Gastroenterological Association (AGA) has announced that their latest guideline, “The AGA Living Guideline: Pharmacological Management of Moderate-To-Severe Ulcerative Colitis,” is now open for public comment. This guideline, aimed at supporting practitioners in the pharmacological management of moderate-to-severe ulcerative colitis (UC), features 14 recommendations designed to guide therapy decisions with a patient-centered approach. Referred […]

Guidelines Side-By-Side Psoriatic Arthritis

Analyzing Guidelines for Psoriatic Arthritis (PsA) – Guidelines Side-By-Side

Psoriatic arthritis (PsA) is a chronic, immune-mediated inflammatory arthritis that occurs most commonly in some people with psoriasis, a skin condition characterized by red, scaly patches. Research suggests that approximately 20-30% of people with psoriasis also develop PsA, with the majority of patient’s presenting with skin-related disease that precedes the onset of arthritis symptomatology, though […]

Guidelines Spotlight - Vitamin D for the Prevention of Disease

Vitamin D for the Prevention of Disease – Guidelines Spotlight

The Endocrine Society unveiled its latest guideline, “Vitamin D for the Prevention of Disease,” on June 3rd, 2024. This evidence-based guideline aims to establish clinical guidelines for the use of vitamin D to lower the risk of disease in individuals without established indications for vitamin D treatment or 25(OH)D testing. Recognized for its vital role […]

Guidelines Spotlight - Melanoma & Gynecologic Cancer

SITC May 2024 Guidelines Updates for Melanoma & Gynecologic Cancer – Guidelines Spotlight

The Society for Immunotherapy of Cancer (SITC) recently released focused updates to two of its clinical practice guidelines. This edition of our Guidelines Spotlight series will examine the key changes that you need to be aware of.  Immunotherapy for the Treatment of Gynecologic Cancer Version 1.1 – Updated on May 24, 2024 Guideline Update Comments: […]

Guidelines Spotlight - Epilepsy in Women

Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After in Utero Exposure to Antiseizure Medication – Guidelines Spotlight

A focused guideline update “Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After in Utero Exposure to Antiseizure Medication” was released by the American Academy of Neurology (AAN), the American Epilepsy Society (AES), and the Society for Maternal-Fetal Medicine (SMFM) on May 15, 2024. The new guideline updates the previous 2009 guideline for “Management Issues for Women with […]

Guidelines Side-By-Side IBS

Comparing AGA and ACG Guidelines for Irritable Bowel Syndrome (IBS) – Guidelines Side-By-Side

This week’s Guidelines Side-By-Side Series will compare the irritable bowel syndrome (IBS) guidelines from the two prominent GI-related associations in the United States – AGA and ACG. Below is an overview of the three guidelines that will be compared side-by-side. The AGA guidelines, while technically two separate documents, were published together at the same time. […]

Guidelines Timeline - Heart Failure with Reduced Ejection Fraction (HFrEF)

Comparing ACC Expert Consensus Pathways for Heart Failure with Reduced Ejection Fraction (HFrEF) – Guidelines Timelines

The American College of Cardiology (ACC), in collaboration with the American Heart Association (AHA), is renowned for its extensive publication of cardiology-related clinical practice guidelines. Alongside these guidelines, the ACC also produces Expert Consensus Decision Pathways (ECDPs), which are consensus-based documents aimed at providing valuable insights and recommendations in the field of cardiology. In this […]

Guidelines Rundown Multiple Myeloma

What’s New in Multiple Myeloma Guidelines – Guidelines Rundown

Multiple Myeloma, also known as Myeloma or Plasma Cell Myeloma, is a type of cancer that affects plasma cells, which are responsible for producing antibodies to protect against infections. This disease can present in various ways, ranging from a slow-developing form with minimal protein abnormalities and few malignant cells to a rapidly progressing and life-threatening […]

Guidelines Spotlight - Survivorship Care for People Affected by Advanced or Metastatic Cancer

Survivorship Care for People Affected by Advanced or Metastatic Cancer – Guideline Spotlight

The Multinational Association for Supportive Care in Cancer and the American Society of Clinical Oncology (MASCC-ASCO) have recently published new guidelines entitled “Survivorship Care for Individuals Affected by Advanced or Metastatic Cancer,” on April 29, 2024. These guidelines provide comprehensive and evidence-based recommendations intended to improve the quality of life and optimize the outcomes for […]

USPSTF Announces Proposed Osteoporosis Screening Recommendations

The United States Preventive Services Task Force (USPSTF) has recently unveiled a draft recommendation statement regarding Osteoporosis Screening, which was published online here on June 11, 2024. In their latest recommendations for osteoporosis screening, the USPSTF proposed the following: These updated recommendations closely align with the screening guidelines established in 2018 for the prevention of […]